EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Fetal Pancreas in Growth Restriction: A Prenatal Window Into Metabolic and Genetic Risk

Hadas Miremberg iD, Catharina Bobrow, Noa Feldman iD, Noa Haggiag, Catherine Garel, Gustavo Malinger iD, Karina Krajden Haratz, Sharon Perlman iD

Prenatal Diagnosis · 2025

DOI: 10.1002/pd.70004 ↗

At a glance

Journal article in Prenatal Diagnosis, 2025. Written by Hadas Miremberg and 7 co-authors. Institution: Ultrasound Unit, Tel Aviv Medical Center, Lis Maternity and Women's Hospital, Tel Aviv-Yafo, Israel. Major MEDLINE topics: Fetal Growth Retardation, Pancreas. Cited 1 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Animal models have demonstrated impaired pancreatic islet development in fetal growth restriction (FGR) cases, which can become apparent at or before birth and persist into adulthood, resulting in glucose intolerance. This study assessed the relationship between fetal pancreatic biometry and FGR.

Methods

A retrospective cohort study included fetuses diagnosed with FGR who underwent prenatal ultrasound at a tertiary center. Pancreatic circumference was measured and compared with established normative reference values. Associations between pancreatic size and estimated fetal weight (EFW), abdominal circumference (AC), Doppler findings, gestational age (GA), concurrent gestational diabetes mellitus (GDM), and the presence of anatomical or genetic abnormalities were analyzed.

Results

The study group comprised 69 cases. The mean GA at the ultrasound examination and pancreatic measurement was 31.5 ± 3.5 weeks. Pancreatic circumference was at or smaller than the 50th percentile of normative references in the majority of the cohort (75%), with 36.2% of cases falling below the 10th percentile and 27.5% below the 5th percentile. Pancreas size correlated moderately with EFW ( r = 0.53) and AC ( r = 0.54) but not with GA.

Conclusion

Fetuses with FGR exhibited reduced pancreatic size. These findings highlight the pancreas as a novel imaging marker and warrant further investigation into long‐term metabolic programming.

Subjects

MeSH terms (MEDLINE)

Fetal Growth RetardationPancreasHumansFemalePregnancyRetrospective StudiesUltrasonography, PrenatalAdultGestational AgeFetal WeightDiabetes, Gestational

Author keywords

fetal growth restrictionfetal pancreasprenatal diagnosis

Authors and institutions

  • Ultrasound Unit, Tel Aviv Medical Center, Lis Maternity and Women's Hospital, Tel Aviv-Yafo, Israel.
  • Gray School of Medicine, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel.

ORCID profiles: Hadas Miremberg, Noa Feldman, Gustavo Malinger, Sharon Perlman

Cite

APA

Miremberg, H., Bobrow, C., Feldman, N., Haggiag, N., Garel, C., Malinger, G., Haratz, K. K., & Perlman, S. (2025). Fetal Pancreas in Growth Restriction: A Prenatal Window Into Metabolic and Genetic Risk. Prenatal Diagnosis. https://doi.org/10.1002/pd.70004

Vancouver

Miremberg H, Bobrow C, Feldman N, Haggiag N, Garel C, Malinger G, et al. Fetal Pancreas in Growth Restriction: A Prenatal Window Into Metabolic and Genetic Risk. Prenatal Diagnosis. 2025. doi:10.1002/pd.70004

BibTeX
@article{Miremberg2025,
  author = {Miremberg, Hadas and Bobrow, Catharina and Feldman, Noa and Haggiag, Noa and Garel, Catherine and Malinger, Gustavo and Haratz, Karina Krajden and Perlman, Sharon},
  title = {Fetal Pancreas in Growth Restriction: A Prenatal Window Into Metabolic and Genetic Risk},
  journal = {Prenatal Diagnosis},
  year = {2025},
  doi = {10.1002/pd.70004}
}
Start for free →